Bayer Mulls Dropping Monsanto Name as Brand Headache Cure

  • Executives aiming to build on consumer trust in Europe
  • The companies can “get beyond this image and reputation thing”

Bayer, Monsanto CEOs on $66 Billion Merger

With Bayer AG’s proposed $66 billion purchase of Monsanto Co., the company that invented Aspirin is poised to take on one of the world’s biggest corporate headaches. A potential cure: dropping the Monsanto name.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.